Lifecore Biomedical, Inc. \De\ (LFCR) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$1.1 million.
- Lifecore Biomedical, Inc. \De\'s Profit After Tax rose 8380.63% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 48028.68%. This contributed to the annual value of -$38.7 million for FY2025, which is 42229.25% down from last year.
- Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Profit After Tax of -$1.1 million as of Q2 2025, which was up 8380.63% from -$14.8 million recorded in Q1 2025.
- Lifecore Biomedical, Inc. \De\'s Profit After Tax's 5-year high stood at $15.6 million during Q1 2024, with a 5-year trough of -$38.5 million in Q4 2021.
- Moreover, its 5-year median value for Profit After Tax was -$10.2 million (2021), whereas its average is -$11.0 million.
- Data for Lifecore Biomedical, Inc. \De\'s Profit After Tax shows a peak YoY increase of 21121.35% (in 2023) and a maximum YoY decrease of 91922.87% (in 2023) over the last 5 years.
- Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Profit After Tax (Quarter) stood at -$38.5 million in 2021, then soared by 66.71% to -$12.8 million in 2022, then soared by 211.21% to $14.2 million in 2023, then crashed by 146.14% to -$6.6 million in 2024, then surged by 82.54% to -$1.1 million in 2025.
- Its Profit After Tax was -$1.1 million in Q2 2025, compared to -$14.8 million in Q1 2025 and -$6.6 million in Q4 2024.